$AVRW has very good news with $2,000,000.00 of add
Post# of 106560
(Total Views: 222)
Posted On: 08/23/2023 8:59:49 AM
$AVRW has very good news with $2,000,000.00 of additional funding coming into the company at this time per the latest 10Q filing (See excerpt below, Page 39 of the filing under NOTE 20). This funding boost plus the rising revenues from sales of the company's increasingly successful Seratopical Revolution product line should accelerate the company's advance towards profitability and an up-listing to higher tier trading exchange.
Link:
https://www.otcmarkets.com/filing/html?id=168...eRV-t5HJth
NOTE 20 – SUBSEQUENT EVENTS
The Company has evaluated subsequent events through the filing date of this Quarterly Report, August 14, 2023, and there are no subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements other than the following: On July 31, 2023, the Company entered into a letter agreement (the “Agreement”) with Cure Pharmaceutical, Inc. (f/k/a TF Tech Ventures, Inc.) which extended the July 22, 2023 maturity date of the $2.0 million note receivable received in connection with the Asset Sale. Pursuant to the Agreement, the repayment to the Company will be made in three installments, as follows: $250 thousand within one day of the signing of the Agreement; $250 thousand no later than the earlier of 10 business days or 12 calendar days from the date of the first installment payment; and the remaining balance including accrued interest no later than 30 days from the date of the first installment payment. The Company received the first installment payment in the amount of $250 thousand on August 1, 2023.
Link:
https://www.otcmarkets.com/filing/html?id=168...eRV-t5HJth
NOTE 20 – SUBSEQUENT EVENTS
The Company has evaluated subsequent events through the filing date of this Quarterly Report, August 14, 2023, and there are no subsequent events that would have required adjustment or disclosure in the unaudited condensed consolidated financial statements other than the following: On July 31, 2023, the Company entered into a letter agreement (the “Agreement”) with Cure Pharmaceutical, Inc. (f/k/a TF Tech Ventures, Inc.) which extended the July 22, 2023 maturity date of the $2.0 million note receivable received in connection with the Asset Sale. Pursuant to the Agreement, the repayment to the Company will be made in three installments, as follows: $250 thousand within one day of the signing of the Agreement; $250 thousand no later than the earlier of 10 business days or 12 calendar days from the date of the first installment payment; and the remaining balance including accrued interest no later than 30 days from the date of the first installment payment. The Company received the first installment payment in the amount of $250 thousand on August 1, 2023.
(0)
(0)
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.